therapure-gmp-nucleotides-white-papers-header_950x250

Nucleoside triphosphates (NTPs) are vital components of emerging RNA therapeutics and vaccines. Controlling impurities that may be present in them while understanding key product quality attributes that make them suitable for good manufacturing practice (GMP) production is important for the successful development of these therapeutics and vaccines.

Download the following two white papers to help you recognize major impurities and identify quality attributes when looking for GMP-quality NTPs.

  • Impurity profiling and analysis of TheraPure GMP* nucleotides
  • Quality and consistency of N1-methylpseudouridine triphosphate
quality-attributes-nucleotides-white-papers-thum
*
*
*
*
 
*
*
 In early stages (research & discovery)
 Investigating solutions
 Actively establishing
 Already performing
 Not working in mRNA production

Would you like to discuss mRNA therapeutics solutions with a Thermo Fisher representative?*

 Yes
 No
 I give consent to the Thermo Fisher Scientific group, its affiliates, any of its authorized distributors and agents (“Thermo Fisher Scientific”) to contact me via e-mail, phone calls and other communication methods to inform me of events, services and promotions which Thermo Fisher Scientific believes may be of interest and are useful to me. I am aware that I can withdraw consent by communicating my withdrawal to Thermo Fisher Scientific, including unsubscribing at any time by clicking on the “Unsubscribe” button in any of the emails I receive. I acknowledge that Thermo Fisher will process my Personal Information in accordance with its Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.